logo inner
Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care.
Thrive Here & What We Value• Unlimited self-renewing capacity• Complex cellular engineering• Off-the-shelf cell therapies• Induced pluripotent stem cells (iPSCs)• Controlled cell banks of modified cells• Expanded and differentiated into desired immune effector cells• T-cell differentiation platform</s>
HQ LOCATIONPhiladelphia, Pennsylvania, United States
Open jobs at Century Therapeutics
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024